Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder

Importance: Individuals with schizophrenia are at higher risk for severe COVID-19 illness and severe breakthrough infection following vaccination. It is unclear whether immune response to vaccination differs in this population. Objective: To assess whether anti-SARS-CoV-2 spike antibody titers after...

詳細記述

書誌詳細

主要な著者:	Katlyn Nemani, Livia De Picker, Faith Dickerson, Marion Leboyer, Michele Santacatterina, Fumika Ando, Gillian Capichioni, Thomas E. Smith, Jamie Kammer, Kawtar El Abdellati, Manuel Morrens, Violette Coppens, Emily Katsafanas, Andrea Origoni, Sabahat Khan, Kelly Rowe, R.Sarah Ziemann, Ryad Tamouza, Robert H. Yolken, Donald C. Goff
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2024-07-01
シリーズ:	Brain, Behavior, & Immunity - Health
主題:	Schizophrenia Schizoaffective disorder COVID-19 mRNA vaccine Immunogenicity Antibody response
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2666354624000802
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!